Comprehensive Pharmacy review 3rd edition

7/23/2019 Comprehensive Pharmacy review 3rd edition

1/5

3rd edition

comprehensive

pharmacy review

EDITORS

Leon Shargel P h.D . R.Ph.

Alan H . Mu tnick Ph arm .D. R.Ph.

Paul F. Souney M.S. R.Ph.

Larry N . Swanson Ph arm .D. R.Ph.

Lawrence H . Block P h.D . R.Ph.

Williams

:

Wilkins

W VERLY COM P N Y

B A L T I M O R E P H I L A D E L P H I A L O N D O N P A R IS B A N G K O K

B U E N O S A I R E S

H O N G K O N G

M U N I C H

S Y D N E Y

T O K Y O

W R O C L A W


2/5

Contents

PART I: PHARMACEUTICAL SCIENCES

1 . Drug Product Deve lopment in the Pharmaceutical Industry 1

Anton H . Amann, Leon

Shargel

2 . Pharmaceutical Ca lculations and Statistics 9

James

K. Drennen, III, Riccardo Boni

3 . Pharmaceutical Principles and Drug Dosage Forms 28

Lawrence H. Block, Andrew B. C. Yu

4 . Biopharmaceutics and Drug Delivery Systems 77

Lawrence H. B lock,Charles

C.

Collins

5 . Extemporaneous Prescription Compounding 90

LoydV Allen

6 . Pharmacokinetics 1 08

LeonShargel

7 . Bioavailability and Bioequivalence 132

LeonShargel

8 . Organic Chemistry and Biochemistry 1 41

Edward

F.

La Sala, John D. Leary

9 . Microbiology 1 54

Ralph N. Blomster

1 0 .

Immunology 165

Gail Coodman-Snitkoff, VincentC.LoPresti

1 1 . Biotechnolog ical Products 1 99

AndrewB. C.Yu Godwin W. Fong

1 2 . Med icinal Chemistry and Drug Metabolism 21 0

Marc W. Harrold

1 3 . Pharmacodynamics 246

\ Nelson

S.

Yee, Leon

Shargel


3/5

I 4 . Drugs Affecting the Autonom ic Nervous System and

255

the Neuromuscular Junction

David C. Kosegarten, E dward F. LaSala

1 5 .

Drugs Affecting the Central Nervous System

270

David C. Kosegarten, Edward

F.

LaSala, Scott

F.

Long

1 6 .

Autocoids and Their Antagonists, Non-Narcotic Analgesic-Antipyretics

294

and Nonsteroidal Anti-Inflammatory Drugs

David C. Kosega rten, Edwa rd F. LaSala, Scott F.Long

1 7 . Drugs Affecting the Cardiovascular System

307

David C. Kosegarten, Edward F. LaSala, J. Edward Moreton

1 8 .

Diuretics

326

David C. Kosegarten, Edward F. LaSala, J. Edward Moreton

1 9 . Hormones and Related Drugs

333

Marc W. Harrold, Pui-Kai Li

20.

Drug Interactions

352

Leon Shargel

2 1 .

Nuclear Pharmacy

360

Stephen C. Dragotakes, Ronald J. Callahan

PART II : PHARMACY PRACTICE

2 2 . Pharmaceutical Care and the Scope of Pharmacy Practice

383

Peggy C. Yarborough

23.

Drug Information Resources

393

Paul

F.

Souney, Connie Lee Barnes

24.

Federal Pharmacy Law

403

Robert C. Pavlan, Jr.

2 5 . Reviewing and Dispensing Prescriptions and Medication Orders

428

Todd A. Brown

26.

Sterile Products

436

ErnestR. Anderson, Jr.

27.

Parapharmaceuticals, Hom e Diagnostics, and Med ical Devices

452

Todd A. Brown

2 8 .

Nonprescription Med ication: An Overview

463

Larry N. Swanson

v i


4/5

29 OTC Otic, Dental,andOphtha lmic Agents

471

Larry N. Swanson, Connie LeeBarnes ConstanceA. M cKenzie

30 OTC AgentsforPediculosis, Acne,SunProtection, 488

and Contact Dermatitis

Larry N.Swanson

3 1 .

OTCWeight ControlandSleep Aids 508

Larry N.Swanson

32 OTC AgentsforFever, Pain, Cough,Cold,and Allergic Rhinitis 518

GeraldE.

Schumacher

Larry N. Swanson

33 OTC AgentsforConstipation, Diarrhea, H emorrhoids,andHeartburn 536

StephenH.Fuller LarryN.Swa nson, JulianneB. Pinson

34 OTCMenstrual, Vag inal,andContraceptive Agents 558

ConstanceA. McKenzie, LarryN. Swanson

3 5 . Clinical Toxicology 569

JohnJ. Ponzillo

36 Therapeutic Drug Monitoring 584

LyndonD. Braun

37

Drug

Use in

Special Patient Populations: Pediatric, Pregnant, Geriatric

598

AlanH.Mutnick, H. Wil l iam McGhee

38 Common Clinical Laboratory Tests 611

Larry N. Sw anson,

D.

Byron

May

39 Ischemic Heart Disease 630

arbara Szymusiak-Mutnick

40 Cardiac Arrhythmias 646

Alan

H.

Mutnick

4 1 .

Systemic Hypertension 669

AlanH.Mutnick

42 Congestive Heart Failure

691

AlanH.Mutnick

43 Infectious Diseases 705

Paul

F.

Souney

Cheryl A. Stoukides

44

Seizure Disorders

750

AzitaRazzaghi

45 Parkinson's Disease 769

Azita

Razzaghi

v ii


5/5

4 6. Schizophrenia 782

Helen L. Figge

47. Affective Disorders 791

Helen L. Figge

48. Asthma and Chronic Obstructive Pulmonary Disease 806

Laura Wilson, Mary Ann Dzurec

49. Rheumatoid Arthritis 827

Larry N. Swan son

50. Hyperuricemia and Gou t 839

Larry N. Swanson

5 1 .

Peptic Ulcer Disease 850

PaulF.Souney CherylStoukides

52 . Diabetes Me llitus 870

Helen L. Figge

53 . Thyroid Disease 882

JohnE.Janosik

54 . Renal Failure 899

Andrew

L.

Wilson

55. Principles of Cancer Chemotherapy 91 5

Amy

J.

Becker

56 . Pain 928

David

R.

Platt

57. Nutrition and the Hospitalized Patient 940

Robert

A. Quercia, Kevin

P.

Keating

58. Immunosuppressive Agents in Organ Transplantation 954

David I. Min

Appendix A:Prescription Dispensing Information and Metrology 961

Appendix B:Common Prescription Drugs and 969

Over-the-Counter Products

Appendix C:Reference Charts Useful for Patient Counseling 979

Appendix D: State and National Pharmacy Organizations 1001

Appendix E:Budgeting for Drug Information Resources 1016

Documents

Comprehensive Pharmacy review 3rd edition